Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles

Journal of Neurology

Volumn 254, Issue 10, 2007, Pages 1407-1413

  Hagenah, J M ^a   Konig I R ^a   Becker, B ^a   Hilker, R ^b   Kasten, M ^a   Hedrich, K ^a   Pramstaller, P P ^c   Klein, C ^a   Seidel, G ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Parkin mutations; Parkinson's disease; Substantia nigra hyperechogenicity; Transcranial ultrasound

Indexed keywords

18 FLUORODOPA; PARKIN; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GENE MUTATION; HEALTH STATUS; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA;

ADULT; ALLELES; COHORT STUDIES; FEMALE; FLUORINE RADIOISOTOPES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; ROC CURVE; SUBSTANTIA NIGRA; UBIQUITIN-PROTEIN LIGASES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 36148995473     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0567-y     Document Type: Article

References (19)

1. Becker G, Berg D (2001) Neuroimaging in basal ganglia disorder: perspectives for transcranial ultrasound. Mov Disord 16:23-32
2. Behnke S, Berg D, Becker G (2003) Does ultrasound disclose a vulnerability factor for Parkinson's disease? J Neurol 250(Suppl 1):I24-I27
3. Berg D, Becker G, Zeiler B, et al. (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 54:1026-1031
4. Berg D, RoggendorfW, Schröder U, et al. (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999-1005
5. Berg D, Schweitzer K, Leitner P, et al. (2005) Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain 128:3000-3011
6. Berg D,Merz B, Reiners K,Naumann M, Becker G (2005) Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 20:383-385
7. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Tredici KD (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134
8. Buhmann C, Binkofski F,Klein C, et al. (2005) Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain 128:2281-2290
9. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
10. Hagenah J,Hedrich K, Becker B, Pramstaller PP, Seidel G,Klein C (2006) Distinguishing early-onset PD from dopa-responsive dystonia with transcranial sonography. Neurology 66:759-761
11. Hedrich K,Winkler S,Hagenah J, et al. (2006) Recurrent LRRK2 (PARK8) mutations in early-onset Parkinson's disease. Mov Disord 21:1506-1510
12. Hedrich K,Kann M, Lanthaler AJ, et al. (2001) The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10:1649-1656
13. Helmchen C, Schwekendiek A, Pramstaller PP, et al. (2006) Blink amplitude but not saccadic hypometria indicates carriers of Parkin mutations. J Neurol 253:1071-1075
14. Hilker R,Klein C, Ghaemi M, et al. (2001) Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 49:367-376
15. Khan NL, Scherfler C,Graham E, et al. (2005) Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Neurology 64:134-136
16. Klein C, Pramstaller PP, Kis B, et al. (2000) Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 48:65-71
17. Spiegel J,Hellwig D, Möllers M-C, et al. (2006) Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 129:1188-1193
18. Walter U,Klein C,Hilker R, et al. (2004) Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19:1445-1449
19. Zecca I, Berg D, Arzberger T, et al. (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20:1278-1285